TY  - JOUR
AU  - Hermann, M. M.
AU  - van Asten, F.
AU  - Muether, P. S.
AU  - Smailhodzic, D.
AU  - Lichtner, P.
AU  - Hoyng, C. B.
AU  - Kirchhof, B.
AU  - Grefkes, C.
AU  - den Hollander, A. L.
AU  - Fauser, S.
TI  - Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to Ranibizumab treatment in age-related macular degeneration.
JO  - Ophthalmology
VL  - 121
IS  - 4
SN  - 0161-6420
CY  - Amsterdam [u.a.]
PB  - Elsevier
M1  - FZJ-2014-02977
SP  - 905 - 910
PY  - 2014
LB  - PUB:(DE-HGF)16
UR  - <Go to ISI:>//WOS:000333808100022
C6  - pmid:24365177
DO  - DOI:10.1016/j.ophtha.2013.10.047
UR  - https://juser.fz-juelich.de/record/153345
ER  -